CORETHERAPIX

Coretherapix engages in creation and development of stents coated medications for cardiac regeneration. The company is based in Spain.

#More

CORETHERAPIX

Industry:
Biotechnology

Address:
Madrid, Madrid, Spain

Country:
Spain

Status:
Active

Contact:
34 918 06 30 89


More informations about "Coretherapix"

Coretherapix - Crunchbase Company Profile & Funding

Coretherapix engages in creation and development of stents coated medications for cardiac regeneration.See details»

Coretherapix Company Profile 2024: Valuation, Investors

Information on acquisition, funding, investors, and executives for Coretherapix. Use the PitchBook Platform to explore the full profile.See details»

Coretherapix - Products, Competitors, Financials, Employees ...

Coretherapix is a clinical stage company focused on developing cost effective regenerative therapies to stimulate the endogenous repair of the heart, and to prevent the negative โ€ฆSee details»

Tigenix announces acquisition of Coretherapix | Reuters

Canadian brewer buys local grain, Chinese cans due to US tariffs · March 5, 2025 · 11:04 AM PST · 14 min ago Phil Smith is going to buy more Canadian grain and Chinese cans as he, โ€ฆSee details»

Coretherapix SL - Drug pipelines, Patents, Clinical trials - Synapse

Explore Coretherapix SL with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»

Business Combination - Acquisition of Coretherapix (Tables)

12 Months Ended Dec. 31, 2017 Business Combination - Acquisition of Coretherapix Summary of fair values of the assets acquired and liabilities assumedSee details»

Coretherapix - Biomedicina - Genetrix

Inicio / Compañías / Biomedicina / CoretherapixMapa web | Contacto | EnglishSee details»

Coretherapix - Biomedicine - Genetrix

Coretherapix is focused on developing myocardial regeneration therapies for preventing the effects of cardiovascular disease during the acute and chronic stages of the myocardial infarction.See details»

CORETHERAPIX SL - Cinco Días

Toda la información de CORETHERAPIX SL Consulta Razón Social Actividad Dirección etc. Informes comerciales, financieros y mercantilesSee details»

Organization | Coretherapix

Coretherapix Report issue For profit Phase 2 Founded: Madrid Spain (2006) Organization Overview First Clinical Trial 2014 NCT02439398 First Marketed Drug None First NDA โ€ฆSee details»

TiGenix acquires Coretherapix - | BioWorld

Mar 2, 2024 Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, โ€ฆSee details»

Heart Attacks: TiGenix advances its cardiac stem-cell therapy

Sep 24, 2015 The TiGenix and CoreTherapix cardiac stem-cell therapy AlloCSC-01 has had positive phase I results, spurring on the phase II Belgium-Spain trial CAREMI.See details»

CORETHERAPIX, SLU Inventions, Patents and Patent Applications

CORETHERAPIX, SLU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been โ€ฆSee details»

coretherapix - Su perfil en Startupxplore

Coretherapix profile at Startupxplore. The European startup funding community. Get found, get funded.See details»

TiGenix NV (TiGenix NV) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ่ฏ•้ชŒ_ๆŠ•่ž่ฅๆ”ถ_ๆœ€ๆ–ฐ โ€ฆ

ไบ†่งฃTiGenix NV (TiGenix NV)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„4้กนไธดๅบŠ่ฏ•้ชŒ, 7็ฏ‡ๆ–ฐ้—ปๅ’Œ1็ฏ‡ๆ–‡็Œฎ๏ผŒๆŠ€ๆœฏๅนณๅฐ:ๅŒ–ๅญฆ่ฏ๏ผŒ้—ดๅ……่ดจๅนฒ็ป†่ƒž็–—ๆณ•๏ผŒ่ฏ็‰ฉ:Darvadstrocel ( โ€ฆSee details»

ADULT CARDIAC STEM CELL POPULATION - CORETHERAPIX SLU

The present invention relates to the identification, isolation, expansion and characterization of a specific type of multipotent adult cardiac stem cell. These adult stem cells are characterised in thSee details»

Be The Cure โ€“ You can help find new cures.

Some data provided by the Clinical Trials Transformation Initiative. Funded in part by the Research Support Fund.See details»

Coretherapix's allogeneic human cardiac stem cells ... - | BioWorld

Coretherapix's allogeneic human cardiac stem cells infusion enters phase I/II clinical trialSee details»

Hospital Organizational Structure and Information Processing: An ...

The structure also provides, to a large extent, insights into what and where information streams should flow in the organization. As certain organizational structures follow certain information โ€ฆSee details»

Community Organising Frameworks, Models, and Processes to โ€ฆ

Community involvement engages, empowers, and mobilises people to achieve their shared goals by addressing structural inequalities in the social and built environment. Through this review, โ€ฆSee details»